Skip to main content
. 2019 Aug 16;20(16):3982. doi: 10.3390/ijms20163982

Figure 7.

Figure 7

Effects of FAK inhibitor PF 431396 on motility and proliferation. (a) Overall average velocities of U-118 MG cells treated with the FAK inhibitor. (b) Overall average velocities of T98G/shL1 cells treated with inhibitor. (c) Overall average velocities of T98G/dFGFR cells treated with inhibitor. (d) U-118 MG cells had decreased proliferation (% S phase population) with the addition of the inhibitor. (e) T98G/shL1 cells had decreased proliferation when compared to the original stimulation. (f) T98G/dFGFR cells also showed a reduction in proliferation when compared to the original stimulation, * p < 0.05, ** p < 0.01.